Public health
Enable IntenseDebate Comments:
Enable IntenseDebate Comments
Army scientists played a key role in testing a new smallpox vaccine approved last week by the U.S. Food and Drug Administration. Marketed under the brand name JYNNEOS, the product, developed by Bavarian Nordic, is a live, non-replicating vaccine for the prevention of both smallpox and monkeypox disease in adults.